Mealey's Patents
-
April 05, 2024
Panel: System, Method For Viewing Large Medical Images Is Patent-Ineligible
WASHINGTON, D.C. — In a blow to the creators of a platform that allows medical personnel to view magnetic resonance imaging (MRI) scans and other large-data medical images on computers and devices with low bandwidth, the Federal Circuit U.S. Court of Appeals on April 4 agreed with a federal judge in Delaware that the claimed technology is not eligible for patenting.
-
April 04, 2024
Board Violated APA When Canceling Claims, Patent Owner Tells Federal Circuit
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals should set aside a final written decision (FWD) by the Patent Trial and Appeal Board that canceled all challenged claims of an electric power grid management patent because the board relied on a theory of invalidity not explicitly raised by Unified Patents LLC’s petition for inter partes review (IPR), a patent owner says.
-
April 04, 2024
Patented Binaural Sound Tech Not Obvious, Owner Argues To Patent Board
ALEXANDRIA, Va. — The prior art relied on by Meta Platforms Inc. in an inter partes review (IPR) instituted in December fails to establish obviousness, the owner of the challenged patent maintains in a response filed April 3 with the Patent Trial and Appeal Board.
-
April 03, 2024
Win For Microsoft Preserved By Federal Circuit In Dispute Over 3D Patent
WASHINGTON, D.C. — A final written decision (FWD) by the Patent Trial and Appeal Board that declared obvious various claims of a patented method for viewing three-dimensional (3D) images will stand, the Federal Circuit U.S. Court of Appeals ruled April 3.
-
April 03, 2024
Supreme Court Turns Down Another Challenge To Abstractness Standard
WASHINGTON, D.C. — A machine company whose technology was deemed patent-ineligible has become the latest party to fail to persuade the U.S. Supreme Court to revisit its decade-old standard for assessing the abstractness of patent claims.
-
April 03, 2024
Accused Of Infringement, Aldi Prevails When Judge Declares Patents Ineligible
CHICAGO — Three patents touted for providing shoppers with the ability to locate branded products in the vicinity via their mobile device recite the abstract idea of collecting, analyzing and displaying information, a federal judge in Illinois has ruled.
-
April 02, 2024
New Jersey Federal Judge Must Revisit Schizophrenia Drug Patent Dispute
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on April 1 remanded a dispute over the validity of a patent directed to an injectable treatment for adult schizophrenia, with the court finding that a New Jersey federal judge’s “misunderstanding of claim scope carried throughout” her obviousness analysis.
-
April 02, 2024
Pandora Prevails, Panel Agrees: Asserted Patents Ineligible For Protection
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals has upheld a judgment of patent ineligibility entered by a California federal judge, agreeing that all claims of three patents asserted against the music streaming service Pandora Media LLC are directed to “nonpatentable subject matter.”
-
March 29, 2024
Panel Orders New Patent Validity Trial, Says Jurors Wrongly Instructed
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals has reinstated a dispute over the validity of patented tamper-resistant containers, agreeing with a patent owner that a Massachusetts federal judge gave an erroneous jury instruction on the objective indicia of nonobviousness.
-
March 29, 2024
In Dispute Over Patented Medical Device, Panel Upholds Denial Of Relief
WASHINGTON, D.C. — Findings by a federal judge in California that substantial questions surround the validity of a patented heart valve testing device at the center of an infringement action will not be disturbed, the Federal Circuit U.S. Court of Appeals ruled March 28.
-
March 29, 2024
Blockchain Technology Correctly Declared Patent-Ineligible, Panel Says
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals has upheld a New York federal judge’s determination that a patented “framework” for determining and recording the unique pattern of imperfections on a gemstone to a blockchain recites the abstract idea of gathering and storing data.
-
March 28, 2024
Federal Circuit: WesternGeco Framework Controls In Cases With Foreign Damages
WASHINGTON, D.C. — A federal judge in Illinois did not abuse her discretion in denying a patent owner a new damages trial, the Federal Circuit U.S. Court of Appeals ruled March 27, rejecting an appellant’s claim that it was entitled to recover hundreds of millions of dollars, not the $6,610,985 it was awarded, but that its efforts to be awarded a higher amount were thwarted when a defendant refused to elaborate on how it was counting infringements.
-
March 27, 2024
Patented Static Seizure Treatment Is Obvious, Petitioner Tells Board
ALEXANDRIA, Va. — A patent owner maintains in a March 26 petition for inter partes review (IPR) that it was the first to disclose, via inherency, a daily dose of ganaxolone for the treatment of status eliepticus (SE), or static seizure, and not a competitor.
-
March 25, 2024
In Dispute Over DNA Sequencing ‘Tag’ Technology, Appellants Seek Extension
WASHINGTON, D.C. — A molecular diagnostics company and its subsidiaries deemed liable by a jury for willfully infringing a patented method of preparing nucleic acids say they need more time to reply to a recent cross-appellant brief, in which the patent owners say there is “no support in the record” for the appellants’ “entire argument on appeal” that “a sequencing primer can only be a primer used to read out a sequence.”
-
March 25, 2024
Patent Owner Tells Board Fintiv Factors All Support Denying Petition
ALEXANDRIA, Va. — Citing the stage of its Texas federal infringement litigation against a petitioner for inter partes review, the owner of an anti-pestware patent on March 22 urged the Patent Trial and Appeal Board to pass on a newly filed invalidity challenge.
-
March 25, 2024
Safe Harbor Ruling In Patent Row Affirmed On Appeal To Federal Circuit
WASHINGTON, D.C. — A divided Federal Circuit U.S. Court of Appeals panel on March 25 upheld findings by a California federal judge that an India-based medical device company is immunized from patent infringement liability for its importation of two transcatheter heart valve systems.
-
March 22, 2024
On Remand From Federal Circuit, Board Reverses Course, Sides With Netflix
ALEXANDRIA, Va. — The Patent Trial and Appeal Board on March 21 issued a new final written decision (FWD) that canceled eight claims of a patented method of decoding encrypted content, nearly one year after the Federal Circuit U.S. Court of Appeals sent the case back to the agency.
-
March 22, 2024
Panel: ‘Skill-Based’ Game Technology Correctly Deemed Patent-Ineligible
WASHINGTON, D.C. — A patent claim directed to an electronic game that is intended to lessen the likelihood of winning by chance and increase the likelihood of winning by skill was correctly deemed ineligible for patenting by a federal judge in Pennsylvania, the Federal Circuit U.S. Court of Appeals ruled March 21.
-
March 21, 2024
Board ‘Stripped,’ ‘Ignored’ Key Limitation In Patent Claims, Owner Says
WASHINGTON, D.C. — A pharmaceutical company is disputing findings by the Patent Trial and Appeal Board (PTAB or board) that its patented form of polymorphic fingolimod hydrochloride is anticipated by prior art, telling the Federal Circuit U.S. Court of Appeals that along the way, the board “ignored” a key limitation which is “indisputably absent from the prior art.”
-
March 21, 2024
Panel Preserves Win For Teleflex, Joins Board In Rejecting Patent Challenge
WASHINGTON, D.C. — The Patent Trial and Appeal Board committed no error in confirming as patentable various claims of a method for “using a coaxial guide catheter in interventional cardiology procedures” owned by Teleflex Life Sciences Ltd., the Federal Circuit U.S. Court of Appeals ruled March 21.
-
March 21, 2024
Decision To Set Aside Jury Award Of Royalties Upheld By Federal Circuit
WASHINGTON, D.C. — A federal judge in California correctly determined that a patent owner failed to establish the amount of a reasonable royalty, requiring vacatur of a jury’s damages award, the Federal Circuit U.S. Court of Appeals said March 20; however, in the same ruling, the panel said the judge must revisit the question of permanent injunctive relief.
-
March 20, 2024
Samsung Seeks Joinder To Meta-Initiated IPR In ‘Understudy’ Role
ALEXANDRIA, Va. — With the apparent blessing of Meta Platforms Inc., Samsung Electronics Co. Ltd. is seeking joinder to an inter partes review of a targeted advertising patent initiated by the social media giant, asserting that its petition contains “substantively identical” grounds and prior art and vowing to assume the role of an “understudy” that will step in only if Meta “ceases to participate.”
-
March 19, 2024
Case Accusing Apple Of Infringing 6 Patents Will Stay In Texas
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on March 18 denied a petition for writ of mandamus, which sought an order directing a Texas federal judge to transfer patent infringement claims leveled against Apple Inc. to the Northern District of California.
-
March 19, 2024
SCOTUS Rejects Patent, Antitrust Claims By Pro Se Petitioner
WASHINGTON, D.C. — An inventor has failed to persuade the U.S. Supreme Court to revive his allegations that Qualcomm Inc. violated antitrust law by tying an infringing central processing unit (CPU) to wireless modems, with the high court on March 18 denying his petition for a writ of certiorari.
-
March 18, 2024
Federal Circuit Won’t Stand In The Way Of Intel License Counterclaim
WASHINGTON, D.C. — A bid by VLSI Technology LLC for reversal of a California federal judge’s decision to allow Intel Corp. to amend its pleadings in a protracted patent battle between the parties has failed, with the Federal Circuit U.S. Court of Appeals on March 18 denying VLSI’s petition for a writ of mandamus.